Dr. R.J. van Klaveren

Update Persondata

• cancer
• cell
• dose
• drug
• growth
• health
• lung
• patients
• plasma
• risk
• screening
• subjects

Active as

Publications

(the most recent at the top)

A new ultrafast and high-throughput mass spectrometric approach for the therapeutic drug monitoring of the multi-targeted anti-folate pemetrexed in plasma from lung cancer patients

A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer

Screening for lung cancer with digital chest radiography: Sensitivity and number of secondary work-up CT examinations

Pulmonary ground-glass nodules: Increase in mass as an early indicator of growth

Pulmonary ground-glass nodules: Increase in mass as an early indicator of growth

All publications..

Completed research projects

(the most recent research is at the top)
Project leader	Phase I dose escalation study of Cisplatin, Pemetrexed and Radiotherapy for inoperable stage III non-small-cell lung cancer (NSCLC)
Project leader	(NELSON-screening trial) in high risk subjects: subsequent screens and evaluation